ARTICLE | Company News
Neurologix, Keio University deal
May 23, 2005 7:00 AM UTC
NRGX received exclusive worldwide rights to use the university's humanin gene to develop and commercialize therapeutics to treat brain and other CNS disorders. The deal excludes the territory of Japan...